Previous studies reported that ECD promotes cell proliferation by regulating RB/E2F pathway-dependent cell-cycle progression and GLUT4-dependent glycolysis in breast and pancreatic cancer, respectively4,8. The gene discussed is SLC2A4; the disease is pancreatic neoplasm.